SLC19A1 Genetic Variation Leads to Altered Thiamine Diphosphate Transport: Implications for the Risk of Developing Wernicke-Korsakoff's Syndrome.
Journal
Alcohol and alcoholism (Oxford, Oxfordshire)
ISSN: 1464-3502
Titre abrégé: Alcohol Alcohol
Pays: England
ID NLM: 8310684
Informations de publication
Date de publication:
10 Sep 2022
10 Sep 2022
Historique:
received:
02
09
2021
revised:
29
04
2022
accepted:
05
07
2022
pubmed:
12
8
2022
medline:
14
9
2022
entrez:
11
8
2022
Statut:
ppublish
Résumé
Wernicke-Korsakoff syndrome (WKS) is commonly associated with chronic alcohol misuse, a condition known to have multiple detrimental effects on thiamine metabolism. This study was conducted to identify genetic variants that may contribute to the development of WKS in individuals with alcohol dependence syndrome through alteration of thiamine transport into cells. Exome sequencing data from a panel of genes related to alcohol metabolism and thiamine pathways were analysed in a discovery cohort of 29 individuals with WKS to identify possible genetic risk variants associated with its development. Variant frequencies in this discovery cohort were compared with European frequencies in the Genome Aggregation Database browser, and those present at significantly higher frequencies were genotyped in an additional cohort of 87 alcohol-dependent cases with WKS and 197 alcohol-dependent cognitively intact controls. Thirty non-synonymous variants were identified in the discovery cohort and, after filtering, 23 were taken forward and genotyped in the case-control cohort. Of these SLC19A1:rs1051266:G was nominally associated with WKS. SLC19A1 encodes the reduced folate carrier, a major transporter for physiological folate in plasma; rs1051266 is reported to impact folate transport. Thiamine pyrophosphate (TPP) efflux was significantly decreased in HEK293 cells, stably transfected with rs1051266:G, under thiamine deficient conditions when compared with the efflux from cells transfected with rs1051266:A (P = 5.7 × 10-11). This study provides evidence for the role of genetic variation in the SLC19A1 gene, which may contribute to the development of WKS in vivo through modulation of TPP transport in cells.
Identifiants
pubmed: 35952336
pii: 6661372
doi: 10.1093/alcalc/agac032
doi:
Substances chimiques
Reduced Folate Carrier Protein
0
SLC19A1 protein, human
0
Ethanol
3K9958V90M
Folic Acid
935E97BOY8
Thiamine Pyrophosphate
Q57971654Y
Thiamine
X66NSO3N35
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
581-588Subventions
Organisme : Brain Research Foundation
Informations de copyright
© The Author(s) 2022. Medical Council on Alcohol and Oxford University Press. All rights reserved.